Overactive Bladder Clinical Trial
Official title:
The Purpose of This Experiment is to Validate the Previous Clinical Study Results Using the Tetra-NIRS (Near Infrared Spectroscopy) as Compared to the Conventional UDS in the Voiding Procedure. This Evaluation Will Use a Commercially Available Tetra-NIRS Device.
The purpose of this evaluation is to validate the previous clinical study results using the
Tetra-NIRS as compared to the conventional UDS in the voiding procedure. The experiment will
use a commercially available Tetra-NIRS device.
The hypothesis is that the commercially available Tetra-NIRS device, in the clinical
environment, provides data to enhance the analysis using the standard urodynamics equipment
(stand-alone Urodynamic procedure).
This is a study of the commercially available Tetra-NIRS device to confirm the results
collected using the commercially available Tetra-NIRS device. The study will evaluate male
patients with lower urinary tract symptoms (LUTS). The study will also include and evaluate
female subjects with over-active bladder (OAB).
The Tetra-NIRS unit uses near infrared light at 3 different wavelengths to measure changes
in haemoglobin and cytochrome from the detrusor muscle from the human bladder wall. This
process is similar to what is used for cerebral and muscle oxygenation monitoring (e.g.,
pulse oximetry). Previous clinical feasibility studies have identified the correlation
between the changes in haemoglobin and cytochrome and the pressure values obtained during
urodynamics procedures and uroflow procedures.
For this study the Tetra-NIRS results specifically will not be used by the urologist/nurse
to guide in patient management and treatment decisions, but rather will only be used to
collect measurements from the patient. The Tetra-NIRS sensor patch will be adhered to skin
surface where their bladder is located.
For this reproducibility study a minimum of 30 male subjects with LUTS scheduled to undergo
a urodynamics procedure are to be enrolled. Up to 20 female subjects with OAB will be
enrolled. The investigators will attempt to equally enrol male subjects into each of the two
categories including obstructed and non-obstructed groups (equivocal subjects will be
determined by the investigator). Refer to Appendix A for additional information on sample
size justification.
The investigators should seek to enroll a minimum of 10% of the subjects with a Body Mass
Index (BMI) > 30, where BMI is calculated:
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04578899 -
"The Effectiveness of Transvertebral Magnetic Neuromodulation in Patients With Detrusor Overactivity"
|
N/A | |
Active, not recruiting |
NCT03556891 -
Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence
|
N/A | |
Not yet recruiting |
NCT05977634 -
Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder
|
N/A | |
Completed |
NCT01955408 -
Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment
|
N/A | |
Recruiting |
NCT06201013 -
Efficacy and Safety of Vitamin D in the Treatment of OAB-wet in Children
|
N/A | |
Recruiting |
NCT03727711 -
TPTNS: Home vs Hospital Treatment for Overactive Bladder
|
N/A | |
Completed |
NCT00768521 -
A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)
|
Phase 1 | |
Completed |
NCT03625843 -
Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing
|
N/A | |
Completed |
NCT02211846 -
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder
|
Phase 1 | |
Completed |
NCT02835846 -
Investigation of the Effect of the Female Urinary Microbiome on Incontinence
|
Phase 4 | |
Completed |
NCT02857816 -
PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB
|
N/A | |
Completed |
NCT02202031 -
Controlling Urgency Through Relaxation Exercises
|
N/A | |
Withdrawn |
NCT02320201 -
Foot Neuromodulation for Overactive Bladder in Children
|
N/A | |
Completed |
NCT01437670 -
Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin
|
N/A | |
Completed |
NCT01458197 -
A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.
|
Phase 2 | |
Not yet recruiting |
NCT01423838 -
Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder
|
Phase 4 | |
Not yet recruiting |
NCT01409512 -
Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder
|
N/A | |
Withdrawn |
NCT01210859 -
Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents
|
N/A | |
Terminated |
NCT01758848 -
Physical Therapy for Overactive Bladder
|
N/A | |
Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 |